Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients:

Tania Salehi1,2, Nicholas J Montarello2,3, Nishant Juneja3

  • 1Central Northern Adelaide Renal and Transplantation Service, Adelaide, South Australia, Australia.

Kidney360
|April 4, 2022
PubMed

Insights

Arteriovenous fistula (AVF) ligation after kidney transplant significantly reduces left ventricular mass long-term. This cardiovascular benefit may decrease mortality risk in kidney transplant recipients.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • The long-term impact of arteriovenous fistula (AVF) ligation on cardiovascular structure post-kidney transplantation is not well-established.
  • A prior randomized controlled trial (RCT) indicated AVF ligation at 6 months post-transplant reduced left ventricular mass (LVM).
  • This study aimed to assess the sustained effects of AVF ligation on cardiovascular parameters.

Purpose of the Study:

  • To evaluate the long-term evolution of cardiovascular magnetic resonance imaging (CMR)-derived parameters after AVF ligation in kidney transplant recipients.
  • To compare cardiovascular structure at long-term follow-up with measurements taken 6 months post-AVF ligation.

Main Methods:

  • A long-term follow-up observational cohort study was conducted on patients from a previous RCT.
  • Cardiovascular magnetic resonance imaging (CMR) was performed at a median of 5.1 years post-AVF ligation.
  • Changes in left ventricular mass (LVM) and LVM index were compared to 6-month post-intervention measurements.

Main Results:

  • At a median of 5.1 years, statistically significant further reductions in LVM (-17.6±23.0 g, P=0.006) and LVM index (-10.0±13.0 g/m², P=0.006) were observed.
  • These findings indicate a persistent effect of AVF ligation on cardiac remodeling.

Conclusions:

  • The cardiovascular benefits of AVF ligation, specifically LVM and LVM index regression, appear to be sustained over the long term.
  • Continued reduction in cardiac remodeling post-AVF ligation holds potential for significantly decreasing cardiovascular mortality in kidney transplant patients.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
344
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
128
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
67
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
82
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
90